Key facts: Cipla Q4 EBITDA INR9.5bn; JPMorgan upgrade; US run‑rate $800-950m; shares up 8%
Key facts: Cipla Q4 EBITDA INR9.5bn; JPMorgan upgrade; US run‑rate $800-950m; shares up 8%
Key facts: Cipla Q4 EBITDA INR9.5bn; JPMorgan upgrade; US run‑rate $800-950m; shares up 8%
Sector
HEALTHCARE
News Type
MARKET
Impact Level
MEDIUM
AI Sentiment
POSITIVE
Published
15 May 2026
📎 Sources
TradingView | https://www.tradingview.com/news/tradingview:e4f50850e5194:0-key-facts-cipla-q4-ebitda-inr9-5bn-jpmorgan-upgrade-us-run-rate-800-950m-shares-up-8/